Harvard Bioscience
HBIO
HBIO
90 hedge funds and large institutions have $107M invested in Harvard Bioscience in 2022 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 29 increasing their positions, 30 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
19% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 26
43% less capital invested
Capital invested by funds: $187M → $107M (-$80.5M)
Holders
90
Holding in Top 10
2
Calls
$1K
Puts
–
Top Buyers
| 1 | +$2.33M | |
| 2 | +$2.3M | |
| 3 | +$1.71M | |
| 4 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$1.2M |
| 5 |
Millennium Management
New York
|
+$1.13M |
Top Sellers
| 1 | -$6.66M | |
| 2 | -$2.68M | |
| 3 | -$2.21M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.39M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$1.13M |